The objective of this study is to estimate the cost-effectiveness of annual mammography plus MRI screening for breast cancer in BRCA1/2 mutation carriers, as compared to screening with mammography alone, from the perspective of the British Columbia healthcare system, using local cost and outcomes data. Here, BRCA1 is linked to breast carcinoma.